The OXA-232 CRE infections share many associated factors with ESBL Enterobacteriaceae.
The previous use of β-lactam/β-lactamase antibiotics was associated to OXA-232 CRE infections.
In absence of ESBL, OXA-232 CRE infections may be treated with 3rd generation cephalosporin.